Back to News
nNovember 1, 2022
We sit at the forefront of a brand new era for ECGs. Sound dramatic? That’s because it is. CEO Andrew Simpson presents.
"Skip to content\nHome\nProducts\nClinical\nNews\nInvestors\nAbout Us\nContact Us\nINVEST NOW\nNEWS\nWe sit at the forefront of a brand new era for ECGs. Sound dramatic? That’s because it is. CEO Andrew Simpson presents.\nNovember 1, 2022\n\nWe sit at the forefront of a brand new era for ECGs. Sound dramatic? That’s because it is. People think of the conventional ECG as something that will diagnose you with heart disease. It isn’t. We’re moving the new era forward.\n\nContacts\nMEDIA RELATIONS\n\nGene Gephart\nDirector of Marketing\n+1-682-244-2578 (US)\n\ngene.gephart@heartsciences.com\nINVESTOR CONTACT\n\nMark Komonoski – Partner\nIntegrous Communications\nDirect: 877-255-8483\n\ninvestorrelations@heartsciences.com\nwww.integcom.us\n